GPCR
Price
$54.75
Change
+$1.28 (+2.39%)
Updated
Jul 6 closing price
Capitalization
3.89B
30 days until earnings call
Intraday BUY SELL Signals
IMMP
Price
$0.44
Change
+$0.01 (+2.33%)
Updated
Jul 6 closing price
Capitalization
55.87M
57 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GPCR vs IMMP

GPCR vs IMMP Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
GPCR vs. IMMP commentary
Jul 07, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GPCR is a Buy and IMMP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2026
Stock price -- (GPCR: $53.45 vs. IMMP: $0.42)
Brand notoriety: GPCR and IMMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GPCR: 45% vs. IMMP: 59%
Market capitalization -- GPCR: $3.89B vs. IMMP: $55.87M
GPCR [@Biotechnology] is valued at $3.89B. IMMP’s [@Biotechnology] market capitalization is $55.87M. The market cap for tickers in the [@Biotechnology] industry ranges from $134.41B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GPCR’s FA Score shows that 1 FA rating(s) are green whileIMMP’s FA Score has 1 green FA rating(s).

  • GPCR’s FA Score: 1 green, 4 red.
  • IMMP’s FA Score: 1 green, 4 red.
According to our system of comparison, GPCR is a better buy in the long-term than IMMP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GPCR’s TA Score shows that 5 TA indicator(s) are bullish while IMMP’s TA Score has 4 bullish TA indicator(s).

  • GPCR’s TA Score: 5 bullish, 3 bearish.
  • IMMP’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, GPCR is a better buy in the short-term than IMMP.

Price Growth

GPCR (@Biotechnology) experienced а +3.40% price change this week, while IMMP (@Biotechnology) price change was +3.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.94%. For the same industry, the average monthly price growth was +11.46%, and the average quarterly price growth was +1972.07%.

Reported Earning Dates

GPCR is expected to report earnings on Aug 06, 2026.

IMMP is expected to report earnings on Sep 02, 2026.

Industries' Descriptions

@Biotechnology (+0.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GPCR($3.9B) has a higher market cap than IMMP($55.9M). GPCR YTD gains are higher at: -23.149 vs. IMMP (-85.266). IMMP has higher annual earnings (EBITDA): -43.83M vs. GPCR (-218.24M). GPCR has more cash in the bank: 1.46B vs. IMMP (159M). IMMP has less debt than GPCR: IMMP (1.69M) vs GPCR (5.79M). GPCR (0) and IMMP (0) have equivalent revenues.
GPCRIMMPGPCR / IMMP
Capitalization3.9B55.9M6,968%
EBITDA-218.24M-43.83M498%
Gain YTD-23.149-85.26627%
P/E RatioN/AN/A-
Revenue00-
Total Cash1.46B159M918%
Total Debt5.79M1.69M344%
FUNDAMENTALS RATINGS
IMMP: Fundamental Ratings
IMMP
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GPCRIMMP
RSI
ODDS (%)
Bearish Trend 1 day ago
76%
Bullish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
81%
Momentum
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 11 days ago
85%
Bullish Trend 14 days ago
84%
Declines
ODDS (%)
N/A
Bearish Trend 29 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
Aroon
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
GPCR
Daily Signal:
Gain/Loss:
IMMP
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
RSSB30.970.39
+1.28%
Return Stacked Global Stocks & Bonds ETF
DLN97.360.22
+0.23%
WisdomTree US LargeCap Dividend ETF
IWMY19.630.03
+0.16%
Defiance R2000 Target 30 Weekly Dis ETF
BELT38.61N/A
N/A
iShares U.S. Select Equity Active ETF
ALBG7.38N/A
N/A
Leverage Shares 2X Long ALB Daily ETF